Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jack Wadden

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Neuro-Oncology|February 9, 2022
Serial H3K27M cell-free tumor DNA (cf-tDNA) tracking predicts ONC201 treatment response and progression in diffuse midline gliomaEvan Cantor, Kyle Wierzbicki, Rohinton S Tarapore, et al.
Cancer Cell|December 1, 2023
A road map for the treatment of pediatric diffuse midline gliomaCarl Koschmann, Wajd N Al-Holou, Marta M Alonso, et al.
Cancer Cell|March 14, 2025
Effective targeting of PDGFRA-altered high-grade glioma with avapritinibLisa Mayr, Sina Neyazi, Kallen Schwark, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Neuro-Oncology|February 9, 2022
Serial H3K27M cell-free tumor DNA (cf-tDNA) tracking predicts ONC201 treatment response and progression in diffuse midline gliomaEvan Cantor, Kyle Wierzbicki, Rohinton S Tarapore, et al.
Cancer Cell|December 1, 2023
A road map for the treatment of pediatric diffuse midline gliomaCarl Koschmann, Wajd N Al-Holou, Marta M Alonso, et al.
Cancer Cell|March 14, 2025
Effective targeting of PDGFRA-altered high-grade glioma with avapritinibLisa Mayr, Sina Neyazi, Kallen Schwark, et al.
Pageof 2